Mesothelioma: an inviting but challenging target for gene therapy.
Ronald G
RG
Crystal
D019264:Adoptive Transfer / Q000379:methods; D000818:Animals; D017209:Apoptosis / Q000235:genetics / Q000276:immunology; D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000235:genetics / Q000276:immunology; D041722:Genes, Transgenic, Suicide / Q000235:genetics / Q000276:immunology; D016147:Genes, Tumor Suppressor; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000235:genetics / Q000276:immunology; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D008654:Mesothelioma / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D011379:Prognosis; D016372:RNA, Antisense / Q000235:genetics / Q000276:immunology; D014780:Viruses / Q000235:genetics
D019496:Cancer Vaccines; D016207:Cytokines; D016372:RNA, Antisense